Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03802019 · ClinicalTrials.gov registry record · NA
Cigarette Packaging of Low Nicotine Cigarettes
A NA study, sponsored by Abramson Cancer Center at Penn Medicine.
- Completed
- Registry status
- NA
- Development phase
- 219
- Enrollment target
NCT03802019 is a NA study that has completed, run by Abramson Cancer Center at Penn Medicine. The registered enrollment target is 219 participants.
The verdict
NCT03802019, a NA study, has completed, sponsored by Abramson Cancer Center at Penn Medicine.
- COMPLETED
- Registry status
- NA
- Development phase
- 219 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the effect of changes in cigarette package color on smoking behaviors, harm exposure, and risk perceptions when using low nicotine content (LNC) cigarettes.
Interventions
- OTHER LNC Cigarettes + Colored Packaging
- OTHER Own Brand
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2019-09-18 |
| Est. Completion | 2025-08-27 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03802019
The ClinicalTrials.gov registry entry for NCT03802019 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abramson Cancer Center at Penn Medicine, which has 402 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which LNC Cigarettes + Colored Packaging is the first listed.
NCT03802019 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03802019 about?
NCT03802019 is a clinical study titled "Cigarette Packaging of Low Nicotine Cigarettes". The purpose of this study is to examine the effect of changes in cigarette package color on smoking behaviors, harm exposure, and risk perceptions when using low nicotine content (LNC) cigarettes.
What is the current status of trial NCT03802019?
This trial is currently completed. It is a NA study. The enrollment target is 219 participants. The study started on 2019-09-18. Estimated completion is 2025-08-27.
What interventions are being tested in trial NCT03802019?
The interventions under investigation include: LNC Cigarettes + Colored Packaging (OTHER), Own Brand (OTHER).
Who is sponsoring clinical trial NCT03802019?
This trial is sponsored by Abramson Cancer Center at Penn Medicine, which has 402 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.